Linalool as a multi-targeted natural anticancer agent: review on molecular mechanisms, potency, limitations and prospects of translation
Medical Oncology · 03.11.2026 · 43 (12)
DOI: 10.1007/s12032-026-03487-0 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medical Oncology, online erschienen am 03.11.2026. Verfasst von V Nandana und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Karunya Institute of Technology and Sciences, Karunya Nagar, Coimbatore-641114, Tamil Nadu, India. Hauptthemen laut MEDLINE: Acyclic Monoterpenes, Neoplasms, Antineoplastic Agents. Die Arbeit nennt 76 Literaturangaben.
Abstract (Originalsprache)
Linalool is a naturally occurring volatile monoterpene that exhibits significant anticancer potency across several malignancies via multitargeted molecular mechanisms. However, the translational research requires a clear anticancer potency with molecular targets and bioavailability data with respect to cancer type as identified via adequate cell and animal models, which lead to clinical trials. Nevertheless, the translation of linalool for clinical use is restricted by the lack of clinical trials and its limited in vivo bioavailability as reported in pre-clinical studies, high volatility and poor aqueous solubility. Therefore, this review examines the reported anticancer potency, probable molecular mechanisms, bioavailability research findings, and current nanoformulation of linalool for future application as an effective medicine. Inadequate in vivo validation and limited intravenous delivery data further highlight the need for advanced nanoformulation techniques and thorough translational studies. The literature for this review was methodically collected from research findings published between 2000 and 2025, capturing foundational and current breakthroughs on linalool’s anticancer potency. A higher anticancer potency as indicated by low IC_50 values in leukaemia, cervical, oral, and prostate cancer cells and a relatively lower anticancer potency in more resistant models like lung and colorectal malignancies were observed from the research reports. Linalool exerted this anticancer potency in both in vitro and in vivo studies through modulation of many molecular activities and signalling pathways as evidenced by both in vitro and in vivo studies, which is supported by the binding affinity of Linalool towards the signalling proteins observed in the in silico molecular docking studies. The cytotoxicity studies have reported insignificant level of toxicity toward non-cancerous cells, but this evidence is limited to specific experimental models. Advances in nanoformulation, including lipid- and gold-based nanoparticles, have improved linalool’s in vivo stability, bioavailability, targeted distribution, and thus anticancer activity, with a reduction in toxicity in the pre-clinical models. Linalool thus shows consistent multi-pathway targeted anticancer activity in vitro and in vivo, and nanocarrier formulations offer a promising strategy to address its physicochemical limitations; however, given the scarcity of pharmacokinetic, toxicity, and clinical efficacy data in humans, substantial translational and clinical research is needed before its therapeutic potential can be established. Graphical abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, Karunya Institute of Technology and Sciences, Karunya Nagar, Coimbatore-641114, Tamil Nadu, India.
- School of Science, Arts and Management, Karunya Institute of Technology and Sciences, Karunya Nagar, Coimbatore-641114, Tamil Nadu, India.
- Department of Biotechnology and Centre for Cancer Research, Karpagam Academy of Higher Education, Eachanari Post -641021, Coimbatore, Tamil Nadu, India. berlinbiochem@gmail.com.
Zitieren
APA
Nandana, V., Wilson, D. D., Jenitha, V., Raj, G. M., Kokelavani, N. B., Srividhya, M., & Berlin Grace, V. M. (2026). Linalool as a multi-targeted natural anticancer agent: review on molecular mechanisms, potency, limitations and prospects of translation. Medical Oncology, 43(12). https://doi.org/10.1007/s12032-026-03487-0
Vancouver
Nandana V, Wilson DD, Jenitha V, Raj GM, Kokelavani NB, Srividhya M, et al. Linalool as a multi-targeted natural anticancer agent: review on molecular mechanisms, potency, limitations and prospects of translation. Medical Oncology. 2026;43(12). doi:10.1007/s12032-026-03487-0
BibTeX
@article{Nandana2026,
author = {Nandana, V and Wilson, D David and Jenitha, V and Raj, G Monith and Kokelavani, N B and Srividhya, M and Berlin Grace, V M},
title = {Linalool as a multi-targeted natural anticancer agent: review on molecular mechanisms, potency, limitations and prospects of translation},
journal = {Medical Oncology},
year = {2026},
volume = {43},
number = {12},
doi = {10.1007/s12032-026-03487-0}
}
EUVIMED